Member Info for LeBadinho

Hopefully they have negotiated a good deal with Voyager so that they can continue to offer GDBY CBD at favourable prices in the future.

I also hope that this move will show the market that they are fully committed to the clinic business and that this might activate new investors.

And do I see it right that they can acquire up to 25% of Voyager? I think that's not so bad for the future.

Wow. This is unexpected. So if they are selling th extraction part it also says that they will not do CBD at all anymore?

i think the same.

Never know before that GDBY now has the biggest blood testing network in the UK with their 80 locations. With this fact they should be part of this study.

I asked George about more details on the blood testing network topic and why they never shared this information with the stock market. From my perspective, it's a massive milestone for the company the market should know about.

and to add something more:

due to the fact that GDBY has been a canadian company it was necessary to have 6 executive directors. With the move to UK it's only necessary to have at least 3. And I always had the feeling the Marc is not really convinced of the health story and was really bad in selling it to the market.

Well, it saves 180k per year.

from my perspective and to be really honest, I like it.

I never had the feeling the Marc is really standing behind the story. George is way deeper into the clinic business and is driving it. So lets wait for some comments and hopefully an interview with Geremy OR George.

From my perspective it's all about reducing costs. Marc received 200k per year.

earwax is the new gold :D
https://www.goodbodyclinic.com/ear-wax-removal

62 locations already offering the service which is no longer a NHS provided service :D

Thats new
https://www.goodbodyclinic.com/pcr-china

which email? do you know more?

with the loss rate of 1.2mio pounds per quarter compared to the cash of 3mio pounds they do have 2-3 quarters in increase revenues. otherwise they need to raise cash again

https://www.accesswire.com/724518/Goodbody-Health-Limited-Publishes-Financial-Results-Q3-2022

fingers crossed. hoping you#re right.

i don't get it anymore. nearly writing on a daily base to GDBY.

I don't know why they have still not startet shareholder communication in UK via sharecast to inform all possible shareholders. In addition to that, i still don't get it why they are not sharing on a detailed news flow when they add new locations.

I think they added more than 25 locations for earway microsuction. What is the expected revenue?....
Pretty hard currently

800.
have you mathced the entries on health.goodbody.com with goodbodyclinic.com?

https://health.goodbodyclinic.com/our-clinics/

I tried to add new locations to my google map but it is really difficult. Therefor i reached out to GDBY to get an excel sheet with all current location to be able to update it.

https://www.google.com/maps/d/u/1/edit?hl=de&mid=1tw7vKhcoYWBTXrjmg_fOEO7hz_T6xvce&ll=53.22231788509549%2C-3.46850793728561&z=6

Shareprice is just a joke. 3.5p unbelievable

When I took a closer look at the clinic, I noticed that there are many new locations especially for earwax microsuction

Looks like new pharmacies for Scotland. 13 locations. Nice
https://dearspharmacy.co.uk/findus/

@alarno
let's hope so.

But they are way behind the expected clinic numbers they shared earlier this year. They need to change something to get realistic market share when this big study in UK about blood collection will start.

I think Q3 will be released by mid (earliest)/end of November.

They still need to prove the business modell. And not only Marc brought 6 companies to a sale position. Also Geremy did. But it will take way longer than expected.

@MPBUK
thats really bad. That hurts if money is gone and you as an investor have the feeling that the company just did a lot of mistakes.

I don't think they don't care about shareholder issues. I also don't believe that they are incompetent.

I just think that they are not focused enough on the issues due to lack of manpower. They are working on too many topics in parallel. Doing a lot of testings and try to find the right setup. Furthermore, nothing has changed in terms of shareholder communication in the UK.